3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
April 8, 2021 — Abbott today announced it has received European CE mark and Health Canada authorization this week for ...
April 08, 2021
![Comparison showing platelet adhesion to the surface of various coronary artery drug-eluting stents (DES) in a preclinical study that used aspirin only. Abbott said the Xience stent's fluoropolymer is significantly more anti-thrombotic than other DES.[2]](/sites/default/files/styles/content_feed_medium/public/DES_Comparison_thrombus_formation_Stents_Abbott.jpg?itok=mfh9GUz-)
April 6, 2021 — Abbott today announced its Xience stent has received CE mark in Europe for shorter duration of dual anti ...
April 06, 2021
January 20, 2021 — The U.S. Centers for Medicare and Medicaid Services (CMS) revised its National Coverage Determination ...
January 20, 2021
December 21, 2020 — U.S. Food and Drug Administration (FDA) approved updated labeling December 17 for Abbott's HeartMate ...
December 21, 2020
Roxana Mehran, M.D., and Marco Valgimiggle, M.D., present the results of the Xience 90/28 trials that evaluated the use ...
October 19, 2020
Gregg Stone, M.D., presents the results of the PROSPECT ABSORB Trial in a press conference at the 2020 ranscatheter ...
October 17, 2020
October 16, 2020 – Results from the XIENCE 90/28 clinical trials have shown that a shorter course of dual-antiplatelet ...
October 16, 2020
Nick West, M.D., chief medical officer for Abbott, explains the details from a survey of 1,400 patients, physicians and ...
September 21, 2020
Feature | Optical Coherence Tomography (OCT)| Aziz Maksoud M.D., FACC, FSCAI, and Bassem Chehab, M.D., FACC, FSCAI
Although not a new technology, optical coherence tomography (OCT) is the dark horse of imaging that could give ...
September 17, 2020
September 14, 2020 — New global research released by Abbott takes a deep dive into the barriers of cardiovascular ...
September 14, 2020